Enzo Biochem, Inc. Quarterly report pursuant to Section 13 or 15(d)

Net loss per share (Details)

Net loss per share (Details)	3 Months Ended		9 Months Ended
Net loss per share (Details)	Apr. 30, 2015	Apr. 30, 2014	Apr. 30, 2015	Apr. 30, 2014
Weighted Average Stock Options [Member]
Net loss per share (Details) [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	1,358,000	1,172,000	1,113,000	905,000
Unvested Restricted Stock [Member]
Net loss per share (Details) [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	26,000	52,000	26,000	52,000

- Definition

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

+ References + Details